glaxosmithkline
Researchers Crowdsource For Novel Malarial Drugs
Once the domain of IT, researchers have adopted a crowdsourced approach to finding alternatives to artemisinin for malarial treatment.
GHIT Announces Ten New Funding Partnerships
The Global Health Innovative Technology Fund has ten new funding partners that include major global pharmaceutical and biotechnology companies.
MSD Joins A*STAR’s Manufacturing Consortium
Pharmaceutical giant MSD is the latest member of A*STAR's iPSP, a program to boost productivity in the high value chemistry sector.
Five Year Price Freeze For GAVI Graduates
GSK will continue to offer vaccines at discounted prices for up to five years after graduation away from GAVI Alliance support.
China’s Pharma Scandal And The Ethics Of The Global Drug Market
Scientists, clinicians and regulators are worried that tainted and counterfeit medicines are potentially being manufactured in China.
GSK Sacks Chinese R&D Chief Over ‘Misrepresented’ Data
GSK has fired its Chinese research chief over 'misrepresented data' in a 2010 Nature Medicine paper.
Glaxo & Taiwan’s NRPB Sign Clinical Trial Research Pact
Taiwan's National Research Program for Biopharmaceuticals signed yesterday an MOU with GlaxoSmithKline to develop Taiwan as a clinical trial hub in Asia.
GSK, Eddingpharm To Collaborate On Novel Breast Cancer Drug In China
China's Eddingpharm will launch GSK's new drug for advanced or metastatic breast cancer in China.
China Plans To Launch Hepatitis E Vaccine ‘This Year’
After more than a year of scrutiny and inspection, a hepatitis E vaccine developed by Chinese scientists should be available by the end of the year.
GSK And Daiichi Sankyo Joint Venture To Form Largest Vaccines Company In Japan
GlaxoSmithKline and Daiichi Sankyo Co. Ltd. have signed a joint venture agreement to form a vaccines company in Japan.
